Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03384654 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
| First Submitted : | December 20, 2017 |
| First Submitted that Met QC Criteria : | December 20, 2017 |
| First Posted : | December 27, 2017 |
| Last Update Submitted that Met QC Criteria : | June 16, 2022 |
| Last Update Posted : | June 21, 2022 |